Skip to main content
. 2021 Sep 6;10(18):e021362. doi: 10.1161/JAHA.121.021362

Table 1.

Baseline Characteristics of Women With an Observed FMP With At Least 1 Lipid Value and Its Subset Also With At Least 1 Subclinical Cardiovascular Measure

Variables Women With Observed FMP Plus Lipids (n=1554) Women With Observed FMP Plus Lipids and Subclinical CVD Measure (n=890)
Age at baseline, mean (SD), y 46.41 (2.70) 46.28 (2.66)
Age at final menstrual period, mean (SD), y 52.07 (2.85) 52.15 (2.87)
Race, n (%)
White 668 (43.0%) 407 (45.7%)
Black 459 (29.5%) 285 (32.0%)
Chinese 147 (9.5%) 136 (15.3%)
Hispanic 108 (7.0%) 62 (7.0%)
Japanese 172 (11.1%) 0
Education, n (%)
≤High school 378 (24.55) 208 (23.64)
Some college 492 (31.95) 273 (31.02)
College/Postgraduate 670 (43.51) 399 (45.34)
Menopausal status, n (%)
Premenopause 884 (57.1%) 521 (58.8%)
Early perimenopause 663 (42.9%) 365 (41.2%)
Lipid‐lowering medications, n (%) yes 14 (0.9%) 7 (0.8%)
Body mass index, mean (SD), kg/m2 28.22 (7.39) 28.33 (7.15)
Smoking
Never 913 (58.8%) 564 (63.4%)
Former 387 (24.9%) 200 (22.5%)
Current 253 (16.3%) 126 (14.2%)
Estradiol, median (q1, q3), pg/mL 55.12 (32.58, 87.08) 55.12 (34.05, 86.25)
Self‐reported prior angina or myocardial infarction 20 (1.3%) 0
Total cholesterol, mean (SD), mg/dL 194.79 (34.49) 192.92 (33.67)
High‐density lipoprotein cholesterol, mean (SD), mg/dL 56.39 (14.21) 56.55 (13.81)
Low‐density lipoprotein cholesterol, mean (SD) mg/dL 116.34 (31.21) 114.74 (30.22)
Apo A1, mean (SD), mg/dL 149.91 (24.05) 150.00 (24.02)
ApoB, mean (SD), mg/dL 111.54 (30.07) 109.96 (29.25)
Triglycerides, median (q1, q3), mg/dL 89 (65.00, 128.00) 89 (64.00, 127.00)

CVD indicates cardiovascular disease; and FMP: final menstrual period.